London’s Semble raises €34.7 million Series C to scale its healthcare management platform for outpatient providers

Semble, a London-based HealthTech startup helping outpatient providers coordinate care and manage the entire patient journey, has secured a €34.7 million (£30 million) Series C funding round. 

The round was led by European growth investor Revaia, with participation from a second new investor, Partech, alongside continued backing from existing investors Mercia Ventures and Octopus Ventures. 

Morgan Kessous, Partner at Revaia, said, “Semble is building the system of action for modern healthcare – a platform with genuine clinical depth, real scale and the trust of healthcare providers across the UK and France. The European healthcare market is being reshaped – by technology, by demand and by shifting patient expectations – and Semble is exceptionally well positioned to lead it. Revaia is proud to back the company with the investment further strengthening its conviction in the long-term transformation of healthcare.”

Founded in 2018 by Christoph Lippuner and Mikael Landau under the name Heydoc, the company later rebranded as Semble in July 2022. The company is a healthcare management platform for outpatient providers. It was founded to address the lack of coordination in healthcare. 

The company claims to connect and orchestrate every stage of the patient journey, helping solo clinicians, growing group practices, and complex enterprise organisations deliver faster, safer, and more patient-centred care.

According to the company, the investment comes as healthcare providers across the UK and Europe face mounting operational pressure caused by fragmented technology systems, rising patient demand and a generational shift towards private medical insurance and self-pay care models.

Christoph Lippuner, CEO and co-founder of Semble, said: “For years, the industry has tried to address complex systemic issues through disconnected point solutions, but fragmented technology often adds operational complexity for healthcare providers and creates an interrupted experience for patients. 

“What healthcare organisations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end. This investment allows us to rapidly scale that vision across the UK and Europe.”

The platform is open and interoperable by design, and integrates with over 1,200 tools across diagnostics, billing, labs, CRM and more. It reports that currently, over 10 million patients have received care from a clinician using the platform. Its 1,700 customers include notable healthcare brands, including Nuffield Health, Welbeck, Midland Health, London Doctors Clinic, Modality and ProblemShared.

With this funding, the company aims to expand into leading healthcare groups, strengthen its position as the AI orchestration layer in modern care delivery, and establish itself in France, where Semble’s flexible platform has achieved regulatory maturity in under a year. The company has also increased its headcount by over 50% since December 2024.

The post London’s Semble raises €34.7 million Series C to scale its healthcare management platform for outpatient providers appeared first on EU-Startups.